What does ONCOLYTICS BIOTECH INC do?

ONCOLYTICS BIOTECH INC is a public company in the Pharmaceutical Preparations industry. It is registered with the SEC under CIK 0001129928 and trades on NASDAQ under the ticker ONCY.

Is ONCOLYTICS BIOTECH INC profitable?

ONCOLYTICS BIOTECH INC reported a net loss of $28.76M in FY2025. This figure is sourced from its SEC EDGAR 10-K annual report.

How many SEC filings has ONCOLYTICS BIOTECH INC made?

ONCOLYTICS BIOTECH INC has filed 1,000 documents with the SEC since 2006. These include annual reports (10-K), quarterly reports (10-Q), current event notices (8-K), and insider transaction disclosures (Form 4).

ONCOLYTICS BIOTECH INC

ONCY NASDAQ CIK: 0001129928 Pharmaceutical Preparations

View on SEC.gov →

Overview All Filings Annual Quarterly Insiders

Recent Filings

All 1,000 filings →

Form	Description	Date
8-K	FORM 8-K	Mar 20, 2026
8-K	8-K	Mar 19, 2026
4	4	Mar 13, 2026
4	4	Mar 13, 2026
8-K	8-K	Mar 2, 2026
8-K	8-K	Feb 24, 2026
4	—	Feb 13, 2026
4	4	Feb 13, 2026
4	4	Feb 13, 2026
4	—	Feb 13, 2026

Insider Transactions

View all →

No insider transactions loaded yet.

About This Profile

This page aggregates all publicly available SEC EDGAR data for ONCOLYTICS BIOTECH INC. Financial figures are sourced from XBRL-tagged 10-K annual reports. Insider transactions are sourced from Form 4 filings required within two business days of a transaction.

Key Financials

Net Income: ($28.76M) (FY2025)
Total Assets: $7.58M (FY2025)
Operating Income: ($28.73M)

Full financials →

Details

CIK: 0001129928
Ticker: ONCY
Exchange: NASDAQ
First Filing: 2006
Total Filings: 1,000

Pharmaceutical Preparations rankings →